Clinical and Biological Anti-aging Efficacy of a Cosmetic Cream
Exploratory Study to Assess Clinical and Biological Anti-aging Efficacy of a Cosmetic Cream in Women After 2 Months of Daily Use, Under Dermatological Control
1 other identifier
interventional
33
1 country
1
Brief Summary
The aim of the study is to determine the efficacy of the investigational product "Cream " :
- on skin network after 56 days of daily application
- on biological parameters linked to cellular communication involved in senescence
- on sebum composition (metagenomics and metabolomics analysis)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 12, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 7, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 14, 2021
CompletedFirst Submitted
Initial submission to the registry
May 19, 2023
CompletedFirst Posted
Study publicly available on registry
June 8, 2023
CompletedJune 8, 2023
April 1, 2023
2 months
May 19, 2023
May 31, 2023
Conditions
Outcome Measures
Primary Outcomes (5)
Assessment of skin network (SRa parameter) by Fringe projection on silicone rubber replica (on one randomized forearm)
SRa: Average roughness (mm). Average variations in amplitude of the relief integrated into the studied surface.
Change from baseline to Day 57
Assessment of skin network (SRq parameter) by Fringe projection on silicone rubber replica (on one randomized forearm)
SRq: Roughness with regards to the average quadratic plan (mm).
Change from baseline to Day 57
Assessment of sebum metabolites' composition
Metabolomics analysis from sebum samples using mass spectrometry
Change from baseline to Day 57
Assessment of skin metagenomic composition
Metagenomics analysis from sebum samples using targeted DNA sequencing
Change from baseline to Day 57
Expression of cellular communication markers linked to senescence
RNA expression from skin biopsies using RNA-Seq
Day 57
Study Arms (1)
Treated Group
EXPERIMENTALall subjects will apply the study product
Interventions
* frequency of application: Once a day (in the morning) * modalities of application: Apply the cream on face (according to normal conditions of use) and on treated forearm, massage until complete penetration * area: The whole face, neck, neckline and one randomized forearm (external photo-exposed area) the other forearm is untreated * duration of investigational product application: 56 days (a window of + 72 hours is allowed) * quantity: 2 pressures of product for the whole face, neck and neckline and 1 pressure of product for the treated forearm
Eligibility Criteria
You may qualify if:
- sensitive skin (declaratory judgment)
- face skin type: combination to normal skin
- presenting wrinkles and/or finelines on the whole face
- displaying saggy skin on the face (loss of firmness)
- presenting a lack of skin radiance, dull complexion and an inhomogeneous skin on the face
You may not qualify if:
- Related to the treatment/product:
- having had any surgery, chemical or significant invasive dermo-treatment on the experimental area considered by the Investigator liable to interfere with the study data
- having undergone techniques with aesthetic aim on study areas (chemical peel, mechanical dermabrasion, laser, pulsed flash lamp etc.) or having made injections of anti-wrinkle products (collagen, hyaluronic acid, botulinic toxin etc.)
- having applied products with an anti-aging action (Retinoic acid, retinol, retinaldehyde, A.H.A. etc.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Spincontrol
Tours, France
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 19, 2023
First Posted
June 8, 2023
Study Start
October 12, 2021
Primary Completion
December 7, 2021
Study Completion
December 14, 2021
Last Updated
June 8, 2023
Record last verified: 2023-04